Stay updated on Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.

Latest updates to the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page shows a new revision tag: v3.3.2, replacing the previous v3.3.1. This appears to be a system metadata update with no changes to the study information presented.SummaryDifference0.0%

- Check24 days agoChange DetectedThe Publications section now clarifies that PubMed entries are automatically populated and may not all be about the study, and the revision label has been updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check31 days agoChange DetectedRemoved a generic funding/operating status notice from the page. This change does not alter the study details, eligibility criteria, or primary information presented for the trial.SummaryDifference0.2%

- Check45 days agoChange DetectedThe new screenshots show minor UI/layout tweaks to the Study Details page with no changes to core study data, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check52 days agoChange DetectedThe changes appear to be visual/UI adjustments with no evident changes to core study details, inclusion criteria, primary outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedAdded full trial details for the Port Delivery System study (design, criteria, outcomes, sites, and investigators). No deletions were reported.SummaryDifference100%

Stay in the know with updates to Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.